Intermittent preventive treatment for infants using sulfadoxine-pyrimethamine (IPTi-SP) for malaria control in Africa

Overview

WHO recommends IPTi-SP for infants living in areas with moderate-to-high malaria transmission in sub-Saharan Africa. Treatment should be given 3 times during the 1st year of life at intervals corresponding to routine vaccination schedules. This intervention has been shown to reduce clinical malaria, anaemia and severe malaria in children under the age of 1.

This field guide provides the necessary technical and operational information and tools to guide decisions by country-level policy-makers and programme managers around the implementation of IPTi-SP.